Login


Notice: Passwords are now case-sensitive

Remember Me
Register a new account
Forgot your password?

What Will Aetna Do With Coventry Workers' Comp?

By Joe Paduda

Tuesday, August 1, 2017 | 0

That’s a question that’s been around for years, but one that’s being asked more and more these days.

Joe Paduda

Joe Paduda

One clue could be — but probably isn’t — Aetna CEO Mark Bertolini’s evolving view of the purpose of health insurance and health plans.

Bertolini’s personal brushes with mortality (a horrific skiing accident and his son’s cancer diagnosis) have fundamentally changed how he sees the role of health insurance. Unlike other insurance executives, he is pushing Aetna to deliver health defined as “a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.”

That’s what we do in workers’ comp — admittedly, not all that well some times — but that’s our goal: prevent accidents and illnesses, get people healthy and functional if they do get hurt, and keep them that way.

I agree with Bertolini’s perspective.

That being the case, Coventry Workers' Comp Services seems like a valuable asset indeed, with exactly the right people, technology, business models and intellectual property Bertolini needs to transform Aetna.

The question is, does Bertolini understand what he has, or will Aetna continue to treat CWCS as a purely financial asset — a tiny part of a huge health care company valued not for its potential impact on the company as a whole, but for the dollars it delivers to the bottom line?

Rumors persist that CWCS is on the block, rumors without solid evidence behind them. As the work comp services industry continues to consolidate, CWCS’ name will continue to come up in conversations whenever investors are contemplating the next big deal.

While it is possible Aetna will entertain offers for CWCS, the division’s value (as a financial asset) has likely decreased over the past few years. CWCS’ core asset, its provider network, is not the dominant force it once was; the bill review business has dropped off; and under-investment throughout the division has hampered innovation.

What does this mean for you?

Sometimes exactly what you need is right in front of you.

Joe Paduda is co-owner of CompPharma, a consortium of pharmacy benefit managers. This column is republished with his permission from his Managed Care Matters blog.

Comments

Related Articles